Chinese innovative drug developer Suzhou Sinovent Pharmaceutical Technology Co., Ltd. has completed a RMB1 billion (US$146 million) series C financing. This round of financing was jointly led by Loyal Valley Capital and another investment firm whose identity could not be determined. Oceanpine Capital, CICC Qide Fund, and other Chinese local RMB funds also jointly participated […]
Chinese Innovative Drug Startup Sinovent Raises RMB1 Billion comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.